Kartos Therapeutics
As of the edition of 20 October 2026, Kartos Therapeutics runs 2 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
Kartos Therapeutics was acquired.
- Kartos Therapeutics, Inc.: acquired
Drugs by status
| Status | Count |
|---|---|
| Active | 2 |
| Total | 2 |
Where its trials are
- Blood and lymph: 11 trials led
- Cancer: 11 trials led
- Immune system: 2 trials led